Ligand Pharmaceuticals

Biotechnology ResearchFlorida, United States51-200 Employees

Ligand Pharmaceuticals is a biotechnology research company headquartered in Jupiter, Florida, with a staff size reported as 51 to 200 employees. The company supports the clinical development of high-value medicines by providing financing, licensing its technologies, or both, and it aims to build a diversified portfolio of biotech and pharmaceutical revenue streams with relatively low corporate costs. Ligand funds programs in mid- to late-stage drug development in return for economic rights, purchases royalty rights in development-stage or commercial products, and licenses its technology to assist partners in discovery and development. It operates two platform technologies, Captisol, a chemically modified cyclodextrin that enhances drug solubility and stability, and NITRICIL, which enables tunable dosing for proprietary formulations. The company has established alliances and licenses with major pharmaceutical firms including Amgen, Merck, Pfizer, Jazz, Gilead Sciences, and Baxter International. Ligand collaborates with partners to leverage strengths in late-stage development, regulatory management, and commercialization to generate revenue.

Sign up for free to view info

Email Format Employee directory